New hope in reducing rate of HIV infections in women
There’s good news in the fight against HIV. A new South African study has found that a microbicide gel containing the antiretroviral medication, Tenofovir can significantly reduce the rate of HIV infections. The study included almost 900 volunteers and showed that the gel cut a woman’s chances of being infected by 50 percent after the first year.
Broader trials are still needed to confirm the results. For more, we talk with Naomi Rutenberg, vice president and director of the HIV and AIDS program at the Population Council.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.